Stryker’s newly appointed CEO Kevin Lobo has affirmed the company’s acquisition strategy focused on core and key adjacent markets with the $135 million purchase of aneurysm device maker Surpass Medical, announced Oct. 16.
During the firm’s third-quarter earnings call the next day, Lobo’s first since taking over as CEO Oct. 1, the exec...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?